Annual General Meeting - listed company€¦ · verified the contents of this Corporate...
1
Transcript of Annual General Meeting - listed company€¦ · verified the contents of this Corporate...
Singapore O&G Ltd.
Annual General Meeting
26 April 2019
1
This Corporate Presentation has been prepared by the Company and its contents have been reviewed by theCompany’s Sponsor, PrimePartners Corporate Finance Pte. Ltd. (the “Sponsor”), for compliance with the SingaporeExchange Securities Trading Limited (the “SGX-ST”) Listing Manual Section B: Rules of Catalist. The Sponsor has notverified the contents of this Corporate Presentation.
This Corporate Presentation has not been examined or approved by the SGX-ST. The Sponsor and the SGX-ST assumeno responsibility for the contents of this Corporate Presentation, including the accuracy, completeness or correctnessof any of the information, statements or opinions made or reports contained in this Corporate Presentation.
The contact person for the Sponsor is Ms. Keng Yeng Pheng, Director, Continuing Sponsorship (Mailing Address: 16Collyer Quay, #10-00 Income at Raffles, Singapore 049318 and Email: [email protected]).
Disclaimer
2
3 3
5
1.Overview
2. Financial Highlights
3. Corporate Updates & Future Plans
5
Our ServicesOur Services
4
5
Our NetworkOur Network
5
Mt. Elizabeth Novena Specialist Centre
15 Clinics
6 O&G Specialists 3 Cancer Specialists- 2 Breast Surgeons- 1 GynaeOncologist
2 Dermatologists 4 Paediatricians
Gleneagles Medical Centre Paragon
Medical Suites
Thomson Medical Centre
Mt. AlverniaMedical Centre
Farrer Park Hospital
Parkway East Medical Centre
Boon Tiong Road
Mt. Elizabeth NovenaSpecialist Centre
6 6
5
1. Overview
2.Financial Highlights
3. Corporate Updates & Future Plans
Presenter
Presentation Notes
Good morning, I’ll be sharing some key financial highlights of SOG.
Consistent Revenue Growth
7
13,54716,413
28,675 29,902
34,681
2014 2015 2016 2017 2018
Revenue (S$’000) Revenue by Business Segments
59.7%15.3%
22.2%
2.8%
S$20.7 mS$5.3 m
S$7.7 m
S$1.0 m
FY 2018
60.3%12.7%
26.4%
0.7%
S$18.0 mS$3.8 m
S$7.9 m
S$0.2 m
FY 2017
O&GCancer-relatedDermatologyPaediatrics
Presenter
Presentation Notes
The Group has achieved steady revenue growth over the years. In FY18, our revenue increased by 16% to $34.7 mil from $29.9 mil in FY17. The revenue growth was mainly attributed to our O&G and cancer-related segments which increased by $2.7 mil and $1.5 mil respectively. Our new paediatrics segment also saw an increase in revenue of $0.8 mil to $1 mil and a marginal 2% decline for dermatology segment.
8
Stable Profits
9,117
904
2,415
-189
10,929
1,6302,294
-487
FY17 FY18
O&G
FY17 FY18
Cancer-related
FY17 FY18
Dermatology
FY17 FY18
Paediatrics
# Include a non-recurring income of S$1.1 million (net of associated expenses) arising from the Dispute
Stable Profits
Profit from Operations (S$’000) Profit from Operations by Business Segments (S$’000)
5,0406,055
10,396 9,869
13,653#
2014 2015 2016 2017 2018
Presenter
Presentation Notes
Our profit from operations rose 38% from $9.9 mil to $13.7 mil in FY18. By business segments, O&G rose 20% to $10.9 mil and Cancer-related jumped 80% to $1.6 mil, while Dermatology registered a marginal 5% dip and our Paediatrics is still registering a loss as we only started this business segment in July 2017 and it is still in its gestation period.
Stable Profits
9
Net Profit (S$’000) Earnings Per Share (Singapore cents)
4,248
5,341
8,804 8,5079,148
2014 2015 2016 2017 2018
1.091.22
1.86 1.781.92
2014 2015 2016 2017 2018
Presenter
Presentation Notes
Overall, we saw a 7.5% jump in net profit to $9.1 mil in FY18. This translates into earnings per share of 1.92 cents, up from 1.78 cents in FY17.
5
Net Assets
10
Net Asset Value (S$’000)
11,856
24,012
41,644 43,500 44,590
2014 2015 2016 2017 2018
3.03
5.48
8.78 9.12 9.35
2014 2015 2016 2017 2018
Net Asset Value Per Share(Singapore cents)
Presenter
Presentation Notes
The Group’s Net Asset Value increased to $44.6 mil in FY18 from $43.5 mil. And net asset value per share stood at 9.35 cents compared with 9.12 cents in FY17.
5
Dividend Payout
11
S$1,482,400
S$4,660,017
S$7,390,447
S$7,152,045
S$8,105,651
2014
2015
2016
2017
2018 (Dividend per share: 1.70 cents based on 476,803,002 shares for interim and final dividend)
(Dividend per share: 1.50 cents based on 476,803,002 shares for interim and final dividend)
(Dividend per share: 3.10 cents based on 238,401,501 shares for interim and final dividend)
(Dividend per share: 2.03 cents based on 218,000,000 shares for interim dividend and 238,401,501 shares for final dividend)
(Dividend per share: 0.85 cents based on 174,400,000 shares)
Presenter
Presentation Notes
The Group does not have a dividend policy, however, since the listing of the company, we have been paying dividend every year. In line with the Group’s overall performance in FY18, we’ve recommended a final one-tier dividend of 0.90 cents, and together with the 0.80 cents interim dividend made in September last year, total dividend for FY18 is 1.70 cents. This represents 88.6% of net profit after tax.
1212
5
1. Overview
2. Financial Highlights
3.Corporate Updates &Future Plans
High Intensity Focused Ultrasound (HIFU)
Dr. Lee Keen Whye
Three of our O&G medical specialists successfully performed the HIFU procedure, a non-invasive surgical procedure for the treatment of uterine fibroids and adenomyosis, making them one of the pioneer
gynaecologists to perform HIFU in Singapore
Dr. Beh Suan Tiong Dr. Hong Sze Ching
13
Corporate UpdatesNew Specialist Medical Practitioners
14
Dr. Christina Ong, a consultant paediatrician and paediatric gastroenterologist with more than 20 years of clinical experience, joined in November 2018
Dr. Liew Hui Min, a fully accredited specialist consultant in dermatology with more than 12 years of experience and special focus on children and women’s dermatology, joined in December 2018
Dr. Petrina Wong, a fully-accredited specialist in paediatrics with more than 15 years of experience with special focus on childhood respiratory and sleep conditions, joined in February 2019
Corporate UpdatesNumber of Births
15
39,720
42,232 42,185
41,251
39,61539,115
2013 2014 2015 2016 2017 2018
Historical Live Births in Singapore* No. of Babies Delivered by SOG
1,060
1,4621,633
1,728 1,7161,824
2013 2014 2015 2016 2017 2018
* Department of Statistics Singapore - https://www.tablebuilder.singstat.gov.sg/publicfacing/createDataTable.action?refId=13273
Future Plans
16
Continue to recruit like-minded
specialists to expand our suite of
complementary services
Continue to build up our patient loads for
all our business segments
Explore regional expansion
opportunities through joint ventures or
acquisitions
Increase inter-clinic referrals through
synergy awareness
17
Singapore O&G Ltd.
Thank You
